Tim Brighton
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 11
- Hematology top 2%
- Platelet Disorders and Treatments 9
- Blood Coagulation and Thrombosis Mechanisms 6
- Blood groups and transfusion 3
-
- Atrial Fibrillation Management and Outcomes 6
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Emergency Medical Services top 5%
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 2
-
- Heparin-Induced Thrombocytopenia and Thrombosis 4
Tim Brighton
21 papers receiving 845 citations
Peers
Comparison fields: 5 of 77
- Internal Medicine 451
- Hematology 366
- Cardiology and Cardiovascular Medicine 367
- Emergency Medical Services 108
- Immunology and Allergy 86
Countries citing papers authored by Tim Brighton
This map shows the geographic impact of Tim Brighton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Brighton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Brighton more than expected).
Fields of papers citing papers by Tim Brighton
This network shows the impact of papers produced by Tim Brighton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Brighton. The network helps show where Tim Brighton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tim Brighton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 20 | |
| 2 | The first known ChAdOx1 nCoV-19 vaccine-induced thrombotic thrombocytopenia in Australia | 2021 | 1 |
| 3 | 2021 | 4 | |
| 4 | 2016 | 5 | |
| 5 | 2014 | 221 | |
| 6 | 2014 | 24 | |
| 7 | 2013 | 4 | |
| 8 | 2012 | 25 | |
| 9 | 2011 | 81 | |
| 10 | 2011 | 63 | |
| 11 | 2011 | 17 | |
| 12 | 2008 | 17 | |
| 13 | 2008 | 11 | |
| 14 | 2007 | 1 | |
| 15 | 2006 | 29 | |
| 16 | 2005 | 39 | |
| 17 | 2004 | 18 | |
| 18 | 2001 | 65 | |
| 19 | 2000 | 0 | |
| 20 | 1994 | 9 |
About Tim Brighton
Tim Brighton is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 866 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (11 papers), Platelet Disorders and Treatments (9 papers), Atrial Fibrillation Management and Outcomes (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Blood groups and transfusion (3 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Internal Medicine (451 citations), Hematology (366 citations) and Cardiology and Cardiovascular Medicine (367 citations). Tim Brighton has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include BH Chong, CN Chesterman, B Murray, Huyen Tran, Sanjeev Chunilal, Simon McRae, Martin H. Prins, Alexander T. Cohen, Mila Trajanovic and Scott D. Berkowitz. Their work appears in journals such as Blood Coagulation & Fibrinolysis, Blood, The Medical Journal of Australia, Australian and New Zealand Journal of Obstetrics and Gynaecology and International Journal of Sports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.